Resonance Health (ASX:RHT) Capital Expenditure : A$-0.43 Mil (TTM As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

What is Resonance Health Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Resonance Health's cash flow for capital expenditures for the six months ended in Dec. 2023 was A$-0.27 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.43 Mil.

Resonance Health Capital Expenditure Historical Data

The historical data trend for Resonance Health's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resonance Health Capital Expenditure Chart

Resonance Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Capital Expenditure

Get a 7-Day Free Trial

-0.35

-0.25

-0.40

-0.70

-0.47

Resonance Health Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Capital Expenditure	Get a 7-Day Free Trial															-0.44	-0.26	-0.32	-0.15	-0.27

Resonance Health Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.43 Mil.

Resonance Health (ASX:RHT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Resonance Health Ltd (ASX:RHT) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

N/A

Address

141 Burswood Road, Level 1, Burswood, WA, AUS, 6100

Website

https://www.resonancehealth.com

Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, and HepaFat-Scan. The company's operating segment includes Services; Research and Development and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of its revenue from North America and Europe-Middle-East-Africa (EMEA) and also has a presence in Asia/Pacific.

Resonance Health (ASX:RHT) Headlines

No Headlines